When “No” Doesn’t Mean No: The Hidden Crisis in America’s Organ Donation System

A Family’s Devastating Discovery

Two summers ago, Raven Kinser walked into a Virginia Department of Motor Vehicles office with a clear intention: to opt out of organ donation. The 25-year-old deliberately unchecked the donor box on her driver’s license application, reversing an earlier decision she had made in Michigan. It seemed like a straightforward choice, the kind of personal decision that should be honored without question. But six months later, when Raven was declared dead at Riverside Regional Medical Center in Newport News, Virginia, her parents Jeff and Jaime Kinser discovered a disturbing truth—that checked box, that explicit “no,” didn’t matter. The Michigan couple received the life-shattering phone call and drove through the night to reach their daughter, only to learn that her case had been referred to LifeNet Health, the region’s federally designated organ procurement organization. What followed exposed a troubling gap in America’s organ donation system: there is no clear, nationally binding way to opt out, and no guarantee that a recent “no” will override an earlier “yes” from a different state. The Kinsers felt certain their daughter wouldn’t have wanted to proceed with donation, but they had no proof at the time. When Jaime asked about signing a consent form, a LifeNet staff member told her it wasn’t an option because donation was Raven’s “living will.” Meanwhile, Raven’s Virginia driver’s license—which would have proven she’d opted out—hadn’t yet been returned to the family. Two months would pass before they finally received it and could confirm what they’d suspected: Raven had not registered as a donor in Virginia. According to the Kinsers, LifeNet told them Raven’s donor status was based on her older Michigan license, and her Virginia decision apparently wasn’t reflected in the registry the organization consulted.

The Fragmented Patchwork: Fifty States, Fifty Different Rules

The confusion and heartbreak the Kinser family experienced isn’t an isolated incident—it’s a consequence of how America’s organ donation system actually works. The United States doesn’t have a unified national registry or consistent federal standards for organ donation consent. Instead, Americans typically register their organ donation intentions when applying for driver’s licenses through state DMVs, and those decisions remain governed largely by state law. This has created 50 different sets of rules with remarkably little federal regulation of what has become a more than $5 billion industry. In some states, checking the donor box is treated as a binding legal document that families cannot override. In others, the same choice may have different rules about when it takes effect, what it covers, and critically, how it can be revoked. These differences aren’t trivial. State rules determine whether a person’s “gift” is limited to transplantation or also includes research and education. They determine whether the authorization includes tissue donation. And they determine what counts as a valid revocation and when it is legally recognized. Because of this fragmentation, signals can cross when someone changes their mind. When Raven opted out in Virginia, that decision wasn’t necessarily communicated to or recognized by systems in other states. The variations are striking: Michigan’s system reflects donor status changes immediately in the secretary of state’s records, but only affirmative “yes” registrations appear in the actual registry. Virginia’s registry includes only those who have said “yes,” retaining no records of people who select “no.” New Mexico updates driver records in real time but doesn’t transmit status changes to its donor registry. Florida reported more than 1.5 million removals from its donor registry in 2023 alone. Kentucky processed nearly 850,000 donor registrations from 2020 to 2025, but only about 16,000 removals. In 2025, more than 570,000 Texans opted into the registry while over 31,000 requested removal. These wildly different processes create a maze of confusion for families like the Kinsers, who are left wondering which registry was consulted, why their daughter’s most recent decision wasn’t honored, and how an older “yes” could legally outweigh a newer “no.”

The Consent Problem: When Autonomy Becomes Ambiguous

At the heart of this issue lies a fundamental principle of medical ethics: personal autonomy. As bioethicist Margaret McLean from Santa Clara University explains, respect for autonomy—our ability to make our own decisions—allows for both “yes” and “no” decisions, and for changing one’s mind. When a donor revokes consent, McLean argues, that revocation should carry the same ethical and procedural weight as the initial authorization, “perhaps more.” Dr. Adam Schiavi, a neurointensivist who studies end-of-life decision-making, puts it even more directly: “Personal autonomy is paramount to everything. If I say I want to be a donor, or if I say I don’t want to be a donor, that has to take precedence over everything else.” Under state versions of the Uniform Anatomical Gift Act, a donor’s most recent legally valid expression of intent is supposed to control. But the key phrase is “legally valid”—and states differ dramatically in how revocation must be recorded and which registry is considered authoritative when someone has lived in more than one state. These inconsistencies create uncertainty when records conflict across jurisdictions. “It has to be the most recent expression, not the most recent yes,” Schiavi emphasized. Yet the current system often seems designed to preserve the “yes” rather than honor the most recent decision. Organ procurement organizations operate in a unique hybrid position in the healthcare system—they’re private nonprofit entities that hold exclusive, federally authorized contracts to recover organs within defined regions. They’re regulated by the Centers for Medicare & Medicaid Services and overseen by the Health Resources and Services Administration, but that oversight occurs primarily through certification standards, performance metrics, and periodic audits rather than routine public disclosure requirements. With donor registries largely managed at the state level and no unified federal reporting requirement for removals, comprehensive national data on revocations is essentially nonexistent. According to a federal official who spoke anonymously, OPOs have been highly effective at lobbying states to broaden the definition of consent and authorization, shaping how those terms are applied and how easy or difficult it is for someone to opt out.

Trust Eroded: Congressional Scrutiny and Calls for Reform

The issues exposed by cases like Raven Kinser’s have become a point of bipartisan congressional concern. Late last year, the House Ways and Means subcommittee on oversight held a hearing examining what members described as shortcomings in the organ procurement system, including alleged consent failures. The panel’s scrutiny represents a first step toward meaningful accountability that could help restore trust across the system. “The trust in our organ procurement and transplant system has been eroded,” declared Rep. Terri Sewell of Alabama, the panel’s senior Democrat, calling for stronger transparency and oversight to rebuild public confidence. Critics of the system point out that it’s extraordinarily difficult for families to obtain documentation or independently verify how consent determinations were made in disputed cases. The Kinsers learned this firsthand when they couldn’t even access their daughter’s driver’s license in time to challenge LifeNet’s determination. In their subsequent complaint to the Health Resources and Services Administration in December, the Kinsers urged federal regulators to investigate LifeNet’s actions and require OPOs to provide families with documented proof of a donor’s current status at the time of referral. They also called for OPOs—which operate as federally designated regional monopolies but are structured as private nonprofits—to be made subject to public records laws, and for criminal penalties in cases where consent is knowingly misrepresented. “I have also wondered that: why there’s not just one” registry for organ donation, Jaime Kinser said. “If you go to get a firearm, you have one federal place.” The analogy is striking—Americans have more regulatory consistency for purchasing a gun than for making decisions about their own bodies after death. Federal regulators have not indicated whether the Kinsers’ proposals are under consideration, but the conversation is clearly gaining momentum.

Proposals for Change: Modernization and National Standards

Both Congress and federal regulators are now considering changes to the nation’s organ donation system, including how consent is recorded and what should happen when a donor changes their mind. Senator Ron Wyden of Oregon proposed legislation last year to create new federal standards for patient safety, transparency, and oversight of organ transplants, including a formal authorization for hospital or OPO staff to pause organ recovery if there is any “clinical sign of life.” The Department of Health and Human Services has signaled its commitment to reform. HHS press secretary Emily Hilliard said the agency is “committed to holding organ procurement organizations accountable” and to “restoring integrity and transparency” to organ donation policy, calling reforms essential to informed consent and protecting donor rights. The Centers for Medicare & Medicaid Services issued related new guidance on March 11, though this guidance does not address the specific problems highlighted by the Kinsers’ case. More significantly, the Health Resources and Services Administration has launched a sweeping modernization of the Organ Procurement and Transplantation Network, the national system that oversees organ allocation and transplant policy. Federal officials have described the overhaul as the most significant restructuring of the transplant system in decades, aimed at breaking up a long-standing contractor monopoly, strengthening patient safety oversight, and replacing aging technology infrastructure. Central to that effort is modernizing the OPTN’s data systems: improving interoperability, audit trails, and transparency in how decisions are documented and reviewed. A more modern federal data architecture could make it easier to trace which registry was queried, what time stamp controlled, and how a consent determination was reached in disputed donations spanning multiple states. However, the modernization effort would not change the underlying state-by-state legal framework for donor authorization and what counts as a valid “no.” Meanwhile, Donate Life America, a national nonprofit that supports state donor registries, also runs the National Donate Life Registry, a central database that allows people to sign up as organ donors directly. Unlike many DMV systems, the national registry lets people log in at any time to view, update, or remove their registration and print proof of their decision. The organization is also starting a project to let participating states send registrations directly into the national system, creating one place to track donor sign-ups and removals across state lines.

The Path Forward: Balancing Lives Saved with Rights Protected

Each proposed reform comes with trade-offs, and both advocates and OPOs have raised concerns about how they would work in practice. OPOs have argued that current policies protect donation as a legally enforceable gift and prevent families from overriding a loved one’s “yes” in the midst of grief. They maintain that stronger, more durable consent helps reduce missed donations and ultimately saves lives. The Association of Organ Procurement Organizations has stated it “supports strengthening donor registries and enhancing registry interoperability to ensure that an individual’s documented donation decision is honored.” These are legitimate concerns—organ donation saves thousands of lives each year, and the system needs to function efficiently to maximize that life-saving potential. But ethicists have long cautioned that consent must be more than a checkbox and must remain grounded in respect for the donor-patient. In an October position paper on organ transplantation, the American College of Physicians emphasized that clinicians’ primary duty is to the patient in their care, and that maintaining trust requires transparency and safeguards to prevent conflicts of interest. Advocates say these steps still leave unresolved the core problem raised by the Kinser family: the lack of a clear, legally binding way for people to say “no” and for that decision to follow them across state lines. As Arthur Caplan, a professor of bioethics at New York University’s Grossman School of Medicine, noted: “Just doing a dump truck dump of information is not going to do much unless you really apply it through checking and auditing. It could be like the IRS. They don’t have to audit everybody. Just do a spot audit once in a while.” The Kinsers aren’t opposed to organ donation itself—they celebrated Raven’s donation in her obituary and acknowledge that her organs gave others the gift of life. But as they wrote in their complaint to federal regulators: “We are NOT anti-organ donation, and we will never take away the gift of life our oldest daughter gave to others. However, that was not LifeNet’s choice to make.” Their words capture the essence of the problem: This isn’t about whether organ donation is valuable—it clearly is. It’s about whether the system respects people’s fundamental right to make and change their own medical decisions, and whether those decisions are honored when it matters most. Until America creates a unified, transparent system where “no” means no regardless of which state you’re in, families will continue to face the heartbreak the Kinsers experienced—grieving a loved one while questioning whether their final wishes were truly honored.